Executive Lookbook

• M.D., Harvard Medical School
• M.A., Yale University
• B.A., Yale University

• Former transplant surgeon and professor of surgery at Harvard Medical School. Operated a laboratory in transplantation immunology at Massachusetts General Hospital in Boston.
• Founded the Juvenile Diabetes Research Foundation Center for Islet Transplantation in 1998 and served as its director until 2003. Elected president of the American Society of Transplantation in 2005.
• Providing leadership for all NIAID research planning and implementation activities, including helping to prepare and support a strategic vision for NIAID.
• Overseeing an extensive portfolio of basic, clinical, and applied research, as well as product development for biodefense, HIV/AIDS, infectious diseases, and immune-mediated disorders.

• M.D., Johns Hopkins University School of Medicine
• B.A., St. John’s College

• Research areas of special interest have included chronic Granulomatous disease, Job's syndrome (autosomal dominant STAT3 deficiency) and the genetic conditions predisposing people to mycobacterial infections. More recently, he has been interested in genetic conditions associated with severe coccidioidomycosis and acquired forms of anticytokine autoimmunity predisposing to opportunistic infections.
• Recipient of many awards, including American College of Physicians Award for Science, the Boyle Scientific Achievement Award of the Immune Deficiency Foundation, and the American Society for Microbiology Abbott Award.

• M.D., Indiana University School of Medicine
• M.P.H., Johns Hopkins University School of Public Health
• M.S., Cornell University

• Responsible for the strategic and scientific vision for the NIAID Division of Microbiology and Infectious Diseases (DMID) complex national and international research program.  DMID supports basic, preclinical, and clinical investigations into the causes, diagnosis, treatment, and prevention of a broad range of pathogens, including those related to biodefense and emerging infectious diseases.
• Develops and manages strategic collaborative relationships with outside partners focused on advancing DMID’s scientific mission. These partnerships include but are not limited to other NIH institutes and centers, BARDA, CDC, CEPI, and WHO.

• M.D., Boston University School of Medicine

• Developed transformative approaches to data transparency and public access.
• Co-chaired the Immunity and Inflammation Steering Committee of the Foundation for NIH Biomarkers Consortium.
• Provides scientific leadership and programmatic direction for the Division of Allergy, Immunology, and Transplantation extramural research portfolio.

• M.D., University of Michigan
• B.S., University of Michigan

• Pioneered the strategies of immunologically compatible bone marrow transplantation and the adoptive transfer of lymphocytes and has examined the roles of cytokines in treating patients with HIV infection.
• Served in the U.S. Public Health Service Commissioned Corps from 1979 to 2008 where he achieved the rank of Rear Admiral and served as Assistant Surgeon General.
• NIAID liaison with the U.S. Departments of Defense and Homeland Security.
• One of the first investigators to study immunopathogenic mechanisms of HIV disease, ultimately making seminal observations that helped establish the field of HIV immunopathogenesis.

• Masters of Art in Economics 
• The George Washington University

• Budget Officer, NIAAA

• Responsible for the formulation, justification, presentation and execution of annual, reimbursable and multi-year budget appropriation of NIAID totaling $8 Billion.

• Ph.D., Johns Hopkins University
• B.S., University of Maryland

• Played a key role in restructuring the DAIDS-supported clinical trials research networks.
• Actively fostered collaboration and partnerships with other federal agencies, international research organizations, professional societies, foundations, community advocacy groups, and industry.
• Oversees a global HIV/AIDS research portfolio of more than $1 billion and a staff of more than 150 federal employees.

BS, Oglethorpe University

MA, Princeton University

PhD, Princeton University

Associate Director for Science Management, NIAID

Director, Office of Biodefense Research and Surety

• M.D., University of California, San Francisco (UCSF)
• D.Sc., (genetic epidemiology) Netherlands Institute for Health Sciences, Rotterdam
• B.A. (genetics) and M.P.H. (epidemiology), University of California, Berkeley

• Vice Chancellor of Research, UCSF
• Professor of Rheumatology and Chief of the Division of Rheumatology, UCSF
• Professor of Orofacial Sciences, UCSF
• Co-Program Director, Clinical & Translational Sciences Institute, UCSF

• Made seminal discoveries in genetic epidemiology of autoimmune rheumatic disease, including systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome
• Contributed to the identification of more than 30 genes linked to these disorders
• Authored/co-authored more than 250 research papers
• Invited speaker at many international and national scientific meetings
• Elected to the Association of American Physicians, an honor extended to physicians with outstanding credentials in biomedical research
• Recipient of numerous awards while at UCSF, including the Kenneth H. Fye, M.D., endowed chair in rheumatology, the Jean S. Engleman distinguished professorship in rheumatology, and the 2014 Resident Clinical and Translational Research Mentor of the Year. Nominated three times for the Chancellor’s Award for the Advancement of Women. Received the Henry Kunkel Young Investigator Award from the American College of Rheumatology

• M.D., Harvard University
• B.S., Williams College

• Member of the Association of American Physicians, the American College of Rheumatology (ACR), the American Association of Immunologist. Served on the Committee for Research of the ACR, and the Medical and Scientific Advisory Committee for the Lupus Foundation of America, Inc.
• Lead multiple initiatives at the NIAMS and the NIH, including Chair of the NIAMS Centers Evaluation Working Group and co-Chair of the Accelerating Medicines Partnership in rheumatoid arthritis and in lupus.

• M.D., University of Cincinnati
• B.S., St. Lawrence University

• Received the U.S. Public Health Service Physician Researcher of the Year Award, the Paul Bunn Award in Infectious Disease, the Lee C. Howley Prize in Arthritis Research and the Irish Society for Immunology Public Lecture Award.
• Ross Prize in Molecular Medicine Award 2014
• Elected to Institute of Medicine 2015
• The David W. Talmage Lectureship Award 2015
• Nobel Forum Lecture, Stockholm, Sweden 2015
• National Jewish Hospital Distinguished Lecturer 2016
• AAI Distinguished Lecturer 2016
• Society for Investigative Dermatology – Stone Lectureship 2016
• Also received the NIAMS Mentoring Award in 2003 and the NIH “Make a Difference” Office of Equal Opportunity Award in 2006

• M.D., Ph.D., University of Rochester School of Medicine and Dentistry
• B.A. Boston University

• Director, Division of Rheumatology, Cincinnati Children's Hospital Medical Center

• Member of the American College of Rheumatology (ACR) and American Association of Immunologists (AAI).
• Chaired ACR Committee on Research and served on the Board of Directors.
• Serves on Medical and Scientific Advisory Board of the Spondylitis Association of America. 

• B.A. (Chemistry), Mary Baldwin College
• Ph.D. (Pharmacology), Medical College of Virginia

• Program Director, NIAMS/NIH/DHHS
• Research Professor, Departments of Orthopaedics and Pharmacology, University of North Carolina

• Lead multiple initiatives at NIAMS and NIH including Project Officer for the public-private partnership Osteoarthritis Initiative and Project Director for the Foundation for NIH Biomarker Consortium Bone Quality Project
• Received numerous NIH Director’s Awards for work related to the Osteoarthritis Initiative, diagnostic imaging, and biomarker development.
• Kappa Delta Award for Excellence in Orthopaedic Research (ligament growth and development
• Orthopedic Research Society, Fellows Award
• Received numerous NIH and NIAMS Director’s Award for contributions to the Geroscience Summit Team, Interagency Working Group on Medical Imaging, Initiative on Bone Strength, and the NIAMS National Multicultural Outreach Initiative
• Authored more than 60 peer-reviewed publications and several book chapters

•  M.B.A., Cameron University
• B.S. Biology, Indiana University

• Deputy Executive Officer, NIAMS
• Branch Chief, NHLBI Office of Acquisitions
• Active Duty Officer, United States Navy

• Graduate of the Federal Executive Institute
• Navy and Marine Corps Achievement Medals (2)

• Ph.D., University of Tennessee, Knoxville, Tennessee

• Dual appointments as professor for the Department of Biomedical Engineering and Surgery at the University of California at Irvine (UCI).

• Directed UCI’s Beckman Laser Institute and Medical Clinic from 2003-2018.
• Served 20 years as PI for the Laser Microbeam and Medical Program (LAMMP), an NIH National Biomedical Technology Resource Center where several cutting-edge technologies have been developed, commercialized, and disseminated to laboratories and clinics around the world.
• Co-authored more than 450 publications and holds 18 patents for biophotonics technologies and their applications in areas such as cancer, neuroscience and vascular disease.